GGrantIndex
← Leaderboards

Kojo Mensa-Wilmot

University Of Georgia (Uga)

Google Scholar ↗PubMed ↗ORCID ↗
$6,819,342
Attributed
$12,228,720
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,228,720 · 11

By mechanism

R01$9,092,403 · 4
R21$1,230,964 · 3
T32$940,865 · 1
R56$672,488 · 1
R03$292,000 · 2

Top collaborators

Others in their field

Top investigators on “Trypanosoma”

Research focus

TrypanosomaLeadAfrican TrypanosomiasisTrypanosoma Brucei BruceiParasitesPharmaceutical PreparationsDrug DiscoveryMouse ModelProteinsProteomicsPropertyBlood CirculationDoseCellsKnock-DownDrug KineticsScaffoldPre-ClinicalIn VitroSeriesToxic EffectPharmaceutical ChemistryBinding ProteinsLapatinib

Grant awards (31)

Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$666,604
R01 · FY2025 · AI · contact PI
Peach State Bridges to the Doctorate$371,136
T32 · FY2025 · GM · contact PI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$673,815
R01 · FY2024 · AI · contact PI
Peach State Bridges to the Doctorate$384,263
T32 · FY2024 · GM · contact PI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$675,005
R01 · FY2023 · AI · contact PI
Peach State Bridges to the Doctorate$185,466
T32 · FY2023 · GM · contact PI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$681,374
R01 · FY2022 · AI · contact PI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$688,344
R01 · FY2021 · AI · contact PI
Hit-to-lead optimization for sleeping sickness drug discovery$690,774
R01 · FY2019 · AI
Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1$647,208
R01 · FY2019 · AI · contact PI
Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1$686,979
R01 · FY2018 · AI · contact PI
Hit-to-lead optimization for sleeping sickness drug discovery$662,424
R01 · FY2018 · AI
Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1$697,985
R01 · FY2017 · AI · contact PI
Hit-to-lead optimization for sleeping sickness drug discovery$616,674
R01 · FY2017 · AI
Hit-to-lead optimization for sleeping sickness drug discovery$640,299
R01 · FY2016 · AI
Development of HTS assay and screening paradigm to discover new kinase inhibitors$306,700
R01 · FY2015 · AI
Lead Optimization of Lapatinib Analogs for Human African Trypanosomiasis$672,488
R56 · FY2014 · AI · contact PI
Development of HTS assay and screening paradigm to discover new kinase inhibitors$306,700
R01 · FY2014 · AI
Curaxins: Lead Drugs and Target Discovery in the African Trypanosome$185,625
R21 · FY2013 · AI · contact PI
Curaxins: Lead Drugs and Target Discovery in the African Trypanosome$217,900
R21 · FY2012 · AI · contact PI
Protein Kinases of a Trypanosome$222,750
R21 · FY2010 · AI · contact PI
Signaling GPI-phosphlipase C of a Trypanosome$185,625
R21 · FY2010 · AI · contact PI
Signaling GPI-phosphlipase C of a Trypanosome$17,226
R21 · FY2010 · AI · contact PI
Signaling GPI-phosphlipase C of a Trypanosome$217,183
R21 · FY2009 · AI · contact PI
Protein Kinases of a Trypanosome$184,655
R21 · FY2009 · AI · contact PI
PROTEIN SYNTHESIS IN LEISHMANIA$73,600
R03 · FY2005 · AI
PROTEIN SYNTHESIS IN LEISHMANIA$73,600
R03 · FY2004 · AI
ENDOPLASMIC RETICULUM OF TRYPANOSOMATIDS$72,400
R03 · FY2003 · AI
ENDOPLASMIC RETICULUM OF TRYPANOSOMATIDS$72,400
R03 · FY2002 · AI
GPI PHOSPHOLIPASE C OF T BRUCEI$236,311
R01 · FY2001 · AI
GPI PHOSPHOLIPASE C OF T BRUCEI$215,207
R01 · FY2000 · AI